首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1288860

全球過敏性免疫療法市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023年至2030年預測

Global Allergy Immunotherapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

據推測，到2030年，全球過敏免疫療法市場的需求將從2022年的3.27百萬美元達到近7.08百萬美元，在2023-2030年的研究期間，年復合成長率為13.97%。

過敏免疫療法是一種醫學治療方法，用於減少或阻止因接觸草花粉、屋塵蟎和蜂毒等過敏原而引起的過敏發作。典型的治療方法包括定期注射含有少量過敏原的過敏針，引發過敏反應以刺激免疫系統。根據給葯途徑存在不同類型的免疫療法。這種療法的有效性取決於治療方案的長度和過敏原的劑量。

市場動態：

兒童和成人都可以接受過敏免疫治療。在使用過敏免疫療法治療老年人時，會考慮他們預先存在的醫療狀況。過敏原免疫治療的費用因國家和給葯途徑而異。污染水準的上升和過敏反應引起的慢性疾病的流行將成為該市場增長的主要動力。與傳統方法相比，免疫療法在治療過敏性鼻炎、過敏性哮喘、結膜炎（眼睛過敏）或叮咬昆蟲過敏等不同類型的過敏方面的有效性將有利於該市場的增長。所有年齡組患者對基於免疫療法的過敏治療的認識和批准不斷提高，將推動市場增長。增加醫療保健對高品質過敏針的研發投資，以涵蓋幾種類型的已知過敏原，將成為市場助推器。該市場增長的主要障礙是對過敏免疫療法缺乏認識。

該報告涵蓋了波特的五力模型，市場吸引力分析和價值鏈分析。這些工具有助於清楚地瞭解行業結構，並在全球範圍內評估競爭吸引力。

此外，這些工具還對全球過敏免疫療法市場的每個市場區隔進行包容性評估。

區域分析：

這一部分涵蓋了區域分類，強調了北美、歐洲、亞太、拉美、中東和非洲的過敏免疫療法市場的當前和未來需求。此外，報告還關注了所有重要地區的個別應用部分的需求。

該研究報告還涵蓋了市場上主要參與者的全面概況和對全球競爭格局的深入看法。過敏免疫療法市場的主要參與者包括Adamis Pharmaceuticals Corporation、ALK-Abello A/S、Allergy Therapeutics、ASIT Biotech、Circassia、DVB Technologies SA、DESENTUM OY、HAL Allergy BV、HollisterStier Allergy、LETIPharma、Merck KGaA、Mylan NV、Stallergenes Greer plc。這一部分包括對競爭格局的整體看法，其中包括各種戰略發展，如關鍵的合併和收購、未來的能力、夥伴關係、財務概況、合作、新產品的開發、新產品的推出以及其他發展。

如果你有任何定製要求，請寫信給我們。我們的研究團隊可以根據您的需要提供定製報告。

區域展望
簡介
北美洲
- 概述、歷史和預測數據
- 北美洲：按細分市場分類
- 北美洲：按國家分類
- 美國
- 加拿大
- 墨西哥
歐洲
- 概述、歷史和預測數據
- 按部門分類的歐洲
- 歐洲：按國家分類
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 歐洲其他地區
亞太地區
- 概述、歷史和預測數據
- 亞太地區按細分市場分類
- 亞太地區：按國家分類
- 中國
- 印度
- 日本
- 韓國
- 澳大利亞
- 亞太其他地區
拉美地區
- 概述、歷史和預測數據
- 按部門分類的拉美地區
- 拉丁美洲：按國家分類
- 巴西
- 阿根廷
- 秘魯
- 智利
- 拉美其他地區
中東和非洲
- 概述、歷史和預測數據
- 中東和非洲，按細分市場分類
- 中東和非洲：按國家分類
- 沙烏地阿拉伯
- 阿拉伯聯合酋長國
- 以色列
- 南非
- 中東和非洲其他地區

第十章：過敏免疫療法公司的競爭格局

過敏免疫療法的市場競爭
夥伴關係/合作/協議
合併和收購
新產品發布
其他方面的發展

第十一章：公司簡介

公司佔有率分析
市場集中度
Adamis Pharmaceuticals Corporation
- 公司概況
- 產品
- 近期發展情況
ALK-Abello A/S
- 公司概況
- 產品
- 近期發展
Allergy Therapeutics
- 公司概況
- 產品
- 近期發展
ASIT Biotech
- 公司概況
- 產品
- 近期發展
Circassia
- 公司概況
- 產品
- 近期發展
DVB Technologies SA
- 公司概況
- 產品
- 近期發展
DESENTUM OY
- 公司概況
- 產品
- 近期發展
HAL Allergy BV
- 公司概況
- 產品
- 近期發展
HollisterStier Allergy
- 公司概況
- 產品
- 近期發展
LETIPharma
- 公司概況
- 產品
- 近期發展
Merck KGaA
- 公司概況
- 產品
- 近期發展
Mylan NV
- 公司概況
- 產品
- 近期發展
Stallergenes Greer plc
- 公司概況
- 產品
- 近期發展情況

注意- 在公司簡介中，財務細節和最近的發展情況取決於可用性，可能不包括私人公司在內。

簡介目錄圖表

Product Code: VMR11213853

The global demand for Allergy Immunotherapy Market is presumed to reach the valuation of nearly USD 7.08 MN by 2030 from USD 3.27 MN in 2022 with a CAGR of 13.97% under the study period of 2023-2030.

Allergy immunotherapy is a medical treatment used to reduce or stop allergy attacks caused by exposure to allergens like grass pollens, house dust mites, and bee venom. The typical treatment method involves regular allergy shots containing a tiny amount of the allergens triggering the allergic reactions to stimulate the immune system. Different types of immunotherapy exist based on the administration route. The effectiveness of this therapy depends on the length of the treatment program and the dose of the allergen.

Market Dynamics:

Both children and adults can undergo allergy immunotherapy. While treating older adults using allergy immunotherapy, their pre-existing medical conditions are taken into consideration. The cost of the allergen immunotherapy varies by country and administration route. Rising pollution levels and the prevalence of chronic disorders due to allergic reactions will serve as the main impetus for this market's growth. The effectiveness of immunotherapy in treating different types of allergies like allergic rhinitis, allergic asthma, conjunctivitis (eye allergy), or stinging insect allergy compared to traditional methods will benefit this market's growth. Growing awareness and approval for an immunotherapy-based treatment for allergies in patients of all age groups will boost the market growth. Increased healthcare investments in the research and development of high-quality allergy shots to cover several types of known allergens will be a market booster. The major hurdle for the growth of this market is the lack of awareness about allergy immunotherapy.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of allergy immunotherapy.

Market Segmentation:

This section of the allergy immunotherapy market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Treatment Type

Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

By Allergy Type

Allergic Rhinitis
Allergic Asthma
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Regional Analysis:

This section covers regional segmentation which accentuates on current and future demand for Allergy Immunotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the allergy immunotherapy market include Adamis Pharmaceuticals Corporation,ALK-Abello A/S,Allergy Therapeutics,ASIT Biotech,Circassia,DVB Technologies SA,DESENTUM OY,HAL Allergy B.V.,HollisterStier Allergy,LETIPharma,Merck KGaA,Mylan N.V.,Stallergenes Greer plc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ALLERGY IMMUNOTHERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Treatment Type
- 3.7.2 By Allergy Type
- 3.7.3 By Distribution Channel
- 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY TREATMENT TYPE

6.1 Overview by Treatment Type
6.2 Historical and Forecast Data
6.3 Analysis by Treatment Type
6.4 Subcutaneous Immunotherapy (SCIT) Market by Regions
6.6 Sublingual Immunotherapy (SLIT) Market by Regions

7 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY ALLERGY TYPE

7.1 Overview by Allergy Type
7.2 Historical and Forecast Data
7.3 Analysis by Allergy Type
7.4 Allergic rhinitis Market by Regions
7.5 Allergic asthma Market by Regions
7.6 Others Market by Regions

8 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Hospital Pharmacy Market by Regions
8.5 Retail Pharmacy Market by Regions
8.6 Online Pharmacy Market by Regions

9 . GLOBAL ALLERGY IMMUNOTHERAPY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America
- 9.3.1. Overview, Historic and Forecast Data
- 9.3.2. North America By Segment
- 9.3.3. North America By Country
- 9.3.4. United State
- 9.3.5. Canada
- 9.3.6. Mexico
9.4. Europe
- 9.4.1. Overview, Historic and Forecast Data
- 9.4.2. Europe by Segment
- 9.4.3. Europe by Country
- 9.4.4. United Kingdom
- 9.4.5. France
- 9.4.6. Germany
- 9.4.7. Italy
- 9.4.8. Russia
- 9.4.9. Rest Of Europe
9.5. Asia Pacific
- 9.5.1. Overview, Historic and Forecast Data
- 9.5.2. Asia Pacific by Segment
- 9.5.3. Asia Pacific by Country
- 9.5.4. China
- 9.5.5. India
- 9.5.6. Japan
- 9.5.7. South Korea
- 9.5.8. Australia
- 9.5.9. Rest Of Asia Pacific
9.6. Latin America
- 9.6.1. Overview, Historic and Forecast Data
- 9.6.2. Latin America by Segment
- 9.6.3. Latin America by Country
- 9.6.4. Brazil
- 9.6.5. Argentina
- 9.6.6. Peru
- 9.6.7. Chile
- 9.6.8. Rest of Latin America
9.7. Middle East & Africa
- 9.7.1. Overview, Historic and Forecast Data
- 9.7.2. Middle East & Africa by Segment
- 9.7.3. Middle East & Africa by Country
- 9.7.4. Saudi Arabia
- 9.7.5. UAE
- 9.7.6. Israel
- 9.7.7. South Africa
- 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE ALLERGY IMMUNOTHERAPY COMPANIES

10.1. Allergy Immunotherapy Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF ALLERGY IMMUNOTHERAPY INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Adamis Pharmaceuticals Corporation
- 11.3.1. Company Overview
- 11.3.2. Financials
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. ALK-Abello A/S
- 11.4.1. Company Overview
- 11.4.2. Financials
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Allergy Therapeutics
- 11.5.1. Company Overview
- 11.5.2. Financials
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. ASIT Biotech
- 11.6.1. Company Overview
- 11.6.2. Financials
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Circassia
- 11.7.1. Company Overview
- 11.7.2. Financials
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. DVB Technologies SA
- 11.8.1. Company Overview
- 11.8.2. Financials
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. DESENTUM OY
- 11.9.1. Company Overview
- 11.9.2. Financials
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. HAL Allergy B.V.
- 11.10.1. Company Overview
- 11.10.2. Financials
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. HollisterStier Allergy
- 11.11.1. Company Overview
- 11.11.2. Financials
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. LETIPharma
- 11.12.1. Company Overview
- 11.12.2. Financials
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Merck KGaA
- 11.13.1. Company Overview
- 11.13.2. Financials
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Mylan N.V.
- 11.14.1. Company Overview
- 11.14.2. Financials
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Stallergenes Greer plc
- 11.15.1. Company Overview
- 11.15.2. Financials
- 11.15.3. Products
- 11.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Treatment Type (USD MN)
Subcutaneous Immunotherapy (SCIT) Market by Geography (USD MN)
Sublingual Immunotherapy (SLIT) Market by Geography (USD MN)
Analysis Market by Allergy Type (USD MN)
Allergic rhinitis Market by Geography (USD MN)
Allergic asthma Market by Geography (USD MN)
Others Market by Geography (USD MN)
Analysis by Distribution Channel (USD MN)
Hospital Pharmacy Market by Geography (USD MN)
Retail Pharmacy Market by Geography (USD MN)
Online Pharmacy Market by Geography (USD MN)
Global Allergy Immunotherapy Market by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisiton

LIST OF FIGURES

Research Scope of Allergy Immunotherapy Report
Market Research Process
Market Research Methodology
Global Allergy Immunotherapy Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Treatment Type
Market Attractiveness Analysis by Allergy Type
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Treatment Type (USD MN)
Subcutaneous Immunotherapy (SCIT) Market by Geography (USD MN)
Sublingual Immunotherapy (SLIT) Market by Geography (USD MN)
Global Market Analysis by Allergy Type (USD MN)
Allergic rhinitis Market by Geography (USD MN)
Allergic asthma Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacy Market by Geography (USD MN)
Retail Pharmacy Market by Geography (USD MN)
Online Pharmacy Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.